This report describes the baseline experience of the multicenter, Home-Based Assessment study, designed to develop methods for dementia prevention trials using novel technologies for test administration and data collection. Nondemented individuals of 75 years of age or more were recruited and evaluated in-person using established clinical trial outcomes of cognition and function, and randomized to one of 3 assessment methodologies: (1) mail-in questionnaire/live telephone interviews [mail-in/phone (MIP)];
P revention trials for dementia and cognitive loss of aging will require effective, efficient, and economical methods of assessment. Traditional in-person visits to clinical assessment sites are time consuming and costly. Most importantly, they exclude from participation some of the very cohorts at greatest risk for decline, such as those with extreme age, medical illnesses, and immobility. Furthermore, current trials for disease prevention and development of diagnostics have required informants and have recruited convenient samples of highly educated nondiverse populations, despite the evidence that blacks, Latinos, and those living alone without an informant are most likely to experience a costly decline. 1 The Home-Based Assessment (HBA) study was designed to overcome these barriers by assessing elders in their home using a range of technologies for test administration and data collection. Over the past 10 years, the Alzheimer Disease Cooperative Study (ADCS) has identified domains which are critical in the transition from cognitive health to dementia. 2 They include cognition, 3 function, 4 behavior, 5 global clinical status, 6 quality of life, 7 and resource use. 8 In addition, we have begun to develop a screen for self-reported cognitive change. Although early work developed comprehensive inventories that could be used across the span of cognitive status, this current protocol used brief versions selecting items with high sensitivity to change in a normal or mildly cognitively impaired elderly population. Furthermore, we developed a measure of medication adherence as a performance-based "activity of daily living."
In a pilot study, 9 we demonstrated the feasibility of assessing individuals in their home using established and new technologies. Specifically, participating elders were randomly assigned to be assessed using (1) telephone and paper forms that were mailed back to the study site (MIP); (2) an interactive voice recognition (IVR) system that used computer-automated telephone assessment; or (3) an internet-based computer Kiosk (KIO) that was installed in the home of the participant. Results from this pilot study established that these technologies were feasible for use with community-dwelling elders. Here, we describe the initiation and baseline characteristics of the cohort participating in a national, randomized trial to evaluate these assessment methods over 4 years.
METHODS

Site Selection
Recruitment was conducted from 28 sites located in metropolitan areas of the United States and selected by the ADCS on the basis of the completion of a site survey. Selection required confirmation of site access to community-dwelling elders, typically living in concentrated areas including organized independent living facilities and informal neighborhoods with high incidence of elderly residence. In addition, the sites had to identify an internet service provider serving the local community, and demonstrate staff with expertise in clinical trial recruitment who were prepared to conduct the full set-up of the protocol in the home.
Participants
Community-dwelling elders signed written informed consent in accordance with local Institutional Review Board standards and were screened to meet the study criteria. Inclusion criteria were: 75 years of age or older; Mini-Mental State Examination score of Z26 10 ; and independently living (a study partner was desirable, but not required). Exclusion criteria were: dementia; use of prescriptive cognitive-enhancing medication (specifically cholinesterase inhibitors and memantine) at screening; unwillingness to use the study-provided multivitamin; other major medical conditions that cause specific cognitive impairment (neurological conditions including stroke, Parkinson disease, or active major psychiatric illness); and life expectancy of <5 years. At each study site, 1 in 5 enrollees was required to be a member of the minority community; accession was monitored and enrollment at a site was suspended until this ratio was achieved.
Procedures/Timeline
An in-person screening visit was conducted to determine eligibility. It consisted of a medical examination, a neurological exam with specific questions about memory complaint, and a neuropsychological battery taken from the Uniform Data Set of the National Alzheimer Coordinating Center. 11 The tests in the neuropsychological battery included: Logical Memory: Immediate and Delayed; Digit Span: Forward and Backward; Category Fluency: Animal and Vegetable; Trail Making Test: Parts A and B; Digit Symbol Substitution; and Boston Naming Test. In addition, a 24-item ADCS Activities of Daily Living -Mild Cognitive Impairment was administered. 12 The clinician used this assessment battery to exclude those with dementia, and categorized eligible participants as normal or mild cognitive impairment (MCI) on the basis of evidence of memory impairment from interview and available neuropsychological evaluation. An algorithmic categorization of MCI (vs. normal) was made centrally, on the basis of education-adjusted Logical Memory delayed recall scores. 13 Blood was also collected for DNA extraction and apoliprotein E genotyping.
Randomization to HBA Arms
Participants were randomized to one of 3 HBA arms. Two frequencies of assessment were nested within each arm. One of the 2 frequencies common to all arms was quarterly assessment. The second assessment frequency was set at annual visits for IVR and MIP, an interval commonly used in prevention trials. The second frequency for KIO was set at monthly visits, an interval compatible with the automated technology, and possibly capable of capturing change in cognitive status at the earliest stage. (1) MIP: cognitive assessments were conducted by a trained evaluator during in-person telephone calls with the participants. Noncognitive assessment and the experimental medication adherence procedures were conducted by mail-back paper forms. The telephone interactions were initiated by the evaluator contacting the participants at prescheduled times. The mail-in procedures were initiated by site mailings to the participants, who were instructed to provide return responses using preaddressed mailers. Participants in the MIP arm were randomized to be assessed annually or quarterly during the study follow-up period. (2) IVR: assessments in this arm were completed using a computerautomated telephone interface, 14 requiring no live staff time. A standard, large-key telephone was installed in the home of the participant; the toll-free telephone number to access the HBA IVR assessment system; and a unique participant identification number were programmed into the telephone memory system. All cognitive, noncognitive, and medication adherence assessments were administered through a speech-enabled, automated telephone interface. Participant responses were obtained and scored using automated speech recognition technology and/or touchtone keypad entry. Visits were initiated by the participant calling in to the toll-free number at prescheduled times. Study staff were instructed to prompt participants to call if they missed a scheduled calling time. IVR participants were randomized to be assessed annually or quarterly. (3) KIO: a web-based computerized assessment, consisting of a computer kiosk (a touch-screen sensitive flat-panel monitor) with an attached telephone handset for recording verbal responses, was installed in the house and connected to the internet by broadband. This typically required a staff member to attend the installation. All KIO participants required installation of internet access, and the grant covered this expense and the expense of ongoing access for the period of the grant. Cognitive and noncognitive assessments were collected through the internet, requiring no live staff time. The visit was announced several days in advance on the KIO screen, and then on the day of assessment initiated by a flashing screen telling the participant to begin the assessment. Participants were guided through the assessment by an intelligent on-screen prerecorded video assistant. Medication adherence was measured using a separate MedTracker device, 15 with compartments for a supply of vitamins for a week, which the participant was trained to fill weekly. The device recorded date and time of all compartment openings. The KIO participants were assigned to either quarterly or monthly assessments. If the assessment was not completed on time, study staff called the participant as a reminder.
Training Visit
The training visit took place in the home of the participant for the IVR and KIO arms, and either by phone or at the home of the participant for the MIP arm. The training visit consisted of a review of the assessment procedures and a mock demonstration of test-taking by the participant. The baseline experimental assessment was scheduled within the next week.
Baseline Visit
For those in the MIP arm, the cognitive battery was conducted by phone with a live tester; the tester reminded the participant to complete the paper-and-pencil noncognitive instruments and return them as described above. For the other 2 arms, appointments were scheduled using their respective automated technologies. If the visit was not completed as scheduled, staff contacted the participant. No staff time was required for either the cognitive or noncognitive assessment battery for IVR and KIO arms. However, the staff effort to reschedule or provide any assistance to complete the visit was captured on the Efficiency Form, as described below.
Follow-up Visits
Each of the follow-up visits included a repeat of the baseline visit assessment tools, with the addition of medication adherence measurement. The results of these ongoing follow-up visits will be analyzed and reported after study completion.
Experimental Assessments-Cognitive
The cognitive portion of the in-home evaluation included the following tests: (1) 8 The order of the tests was designed to provide a delay of 15 to 20 minutes between the immediate learning and delayed recall for the Word List and East Boston Memory tasks, and to avoid interference from Category Fluency. The expected overall time to administer the experimental cognitive performance battery was 20 to 25 minutes for all 3 arms. The MIP arm, alone, required staff time to collect data, and this was recorded on the Efficiency Form. Each of the cognitive tests was preserved as much as possible to allow delivery by different technologies (ie, live telephone interactions, IVR-automated telephone interactions, and KIO computer-based audiovisual interactions), yet maintain enough features to enable performance comparisons to the standard face-toface measures and across arms. The adaptations of Trail Making Test A and B to each of the in-home formats preserved the elements of following a sequence mentally and dealing with >1 stimulus or thought at a time; however, the original feature of visuomotor tracking could not be preserved, particularly in the IVR and MIP conditions. In the KIO arm, the trails tests were scored on the basis of the participant connecting the appropriate numbers and letters as traced with their finger on the touch-screen. In light of these fundamental differences in adaptation, no inferential statistics were applied to compare Adapted Trail Making Test across groups.
Experimental Assessments-Noncognitive
The noncognitive portion of the home-based experimental assessment was completed by mail for the MIP arm, by automated telephone assessment (keypad and orally) for the IVR arm, and by automated computer kiosk (orally and touch-screen) interaction for the KIO arm. The expected time to complete the noncognitive assessments was 20 minutes. The noncognitive measures 8 14 Participants were instructed to take a study-provided multivitamin in the morning and evening each day. Adherence was measured according to the format of the arm and will be described in other reports.
As with the cognitive tests, there were several differences in presentation of noncognitive items across the 3 arms. In particular for the IADL and the BCFSI, the IVR provides oral presentation only while MIP and KIO display all response choices in writing. Also the order of response option was adjusted to for each methodology.
Efficiency Measures
Two measures of efficiency were used to evaluate the methodologies: (1) the number of days from screening to baseline; and (2) the amount of staff contact required to complete the experimental assessments, as systematically coded on The Efficiency Form. The frequency of contact and length of time spent with the participants in-person or by phone were recorded along with the reason for the contact. These were categorized as follows: Training time (the time to familiarize a participant with tools and teach how to use the equipment and forms); Preparation time (the time in-home to set up the modality and answer questions); Time at baseline (all other nonscheduled contacts, including assurance to participants about the protocol or to remedy equipment problems, and address missing forms); and Testing time (administering the cognitive battery, for the MIP arm only). The Total Time (min) was the sum of these times.
Trigger for In-Person Evaluation During Longitudinal Follow-up
At each follow-up visit, 3 experimental test scores are evaluated to determine if sufficient worsening had occurred to warrant an in-person evaluation that would determine if the participant had indeed progressed to MCI or dementia. These "trigger" tests are Delayed Word Recall, BCFSI, and IADL scale, the latter test score converted to a percentage, with 100% indicating best performance. The algorithm for trigger requires worsening in Z1 of these tests and is specific to the initial participant categorization as either MCI or normal, and assigned frequency of assessment.
Statistical Analyses
The key demographic, clinical, and neuropsychological variables that were collected on the full cohort of participants in-person at baseline were summarized by descriptive statistics. The descriptors for variables that were measured on a continuous scale were: means, SDs, and ranges of scores. Categorical variables (ie, frequency counts) were summarized in percentages.
Statistical comparisons at baseline were conducted across arms on a number of continuous measures using 1-way analysis of variances. These measures were: the 3 trigger experimental variables (Word List: Delayed recall, BCFSI, and IADL) and all efficiency variables: time from screening to baseline in days (d), and the time (min) that staff spent with the participant up to and including the first (baseline) experimental "visit." If Bartlett test of homogeneity of variances was nonsignificant (PZ0.05) for a given variable and the overall F test was significant, a Tukey post hoc analysis was conducted. If Bartlett test was significant (P < 0.05), Welch t tests 16 were conducted to accommodate unequal variances, with Hochberg 17 adjustments for multiple comparisons (ie, pairwise comparisons = MIP:IVR, MIP:KIO, IVR:KIO). The number of times each subject was contacted by site personnel at baseline was modeled as Poisson. All the tests were 2-tailed with a set at 0.05. Statistical analyses were conducted with the R (version 2.14). 18 
RESULTS
A total of 713 community-dwelling seniors were screened ( Fig. 1) , of whom 73 were not eligible. There were no significant differences in age, sex, race, or ethnicity between the group of 640 seniors who met eligibility requirements compared with the group who did not. However, the 640 seniors who were eligible were better educated (t 1,708 = 2.99; P = 0.004), with a mean number of years of education of 15.7 (SD = 2.8), compared with a mean of 14.6 (SD = 2.9) for the 73 persons who failed screening.
Among the 28 participating sites, a mean of 22.9 (SD = 8.6) subjects were randomized per site (range, 5 to 40). Of the 640 subjects who were randomized to one of the 3 study arms, 59 subjects (9.2%) chose to discontinue before the baseline evaluation. There were no significant differences in age, education, sex, minority status, ApoE4 status, history of cardiovascular disease and hypertension, ADL-MCI scores, presence of MCI, or screening Mini-Mental State Examination scores between those who did and did not continue participation. Likewise, within each of the 3 arms there were no significant differences in any of these variables between those who discontinued before baseline and those who completed baseline evaluation. However, there was a significant difference across arms in the dropout rate before baseline evaluation. As noted in Figure 1 , the rate of dropout was 17% for KIO, 8% for IVR, and 2% for MIP (Fisher exact test P < 0.001). In post hoc pairwise Fisher tests, the dropout rate for those participants assigned to the KIO arm was significantly higher than for the MIP (P < 0.001) and IVR (P = 0.009); the dropout for the IVR arm was significantly higher than the MIP arm (P = 0.003). Each of the 3 arms had 2 frequency conditions, and higher frequency was associated with greater dropout for both high-technology arms even before baseline. IVR participants assigned to annual evaluation had a dropout rate of 7% compared with 10% for quarterly; KIO participants assigned to quarterly evaluation had a dropout rate of 15% compared with 20% for monthly; MIP, in contrast, had a dropout rate of 0% for quarterly and a 4% for annual evaluation (Fisher exact test P < 0.001). Reasons for dropout were not categorized but recorded comments indicated inconvenience of equipment (eg, lack of apartment space for the KIO) and too much of a time commitment to participate. Table 1 provides demographic, clinical, and neuropsychological characteristics at baseline. The mean age at baseline was 81.0 years, ranging up to 98 years old; 74% had cardiovascular disease, 19% had MCI at baseline, 25% had Z1 APOE 4 allele, and 28% admitted to a current memory problem by self-report.
The baseline scores on "trigger" tests are included in Table 2 with statistical comparisons across arms. There was no significant difference across arms on the Word List: Delayed recall, and the distribution was similar for both mean and SD values in each of the arms and scores spanned the whole range (0 to 10). The mean BCFSI scores were different among groups (F = 13.4; df = 2,576; P < 0.001) with lower scores (ie, fewer self-reported functional symptoms) in the MIP than both KIO and IVR groups. The variance of the IADL exhibited significant heterogeneity across groups, so pairwise comparisons were analyzed by Welch t tests with Hochberg adjustment for multiple comparisons. The IADL score was the highest (ie, least impaired) in the MIP arm and significantly above the KIO and IVR arms; the KIO scores were significantly higher than the IVR scores. Table 3 presents efficiency measures. The number of days from screening to baseline was greater in the KIO arm (55.7 ± 42.3 d), than in IVR 39.2 ( ± 25.8) and in MIP 33.5 ( ± 25.5), which were not different from each other. The total time (Table 3, 
DISCUSSION
This study examines home-based methods that might be used in dementia prevention trials. Although those who failed the screening process had less education than those who were eligible, the HBA study successfully enrolled a diverse cohort of elders with >20% minority participants and a mean age in the eighth decade. The majority of the sample was female. Cardiovascular disease and hypertension were common, as expected in a group of this age. These clinical and demographic characteristics are associated with the risk of dementia, supporting the notion that we captured the population who would likely be enrolled in prevention studies.
Randomized assignment to the different assessment methods resulted in similar demographic and clinical features among the groups, suggesting that acceptability of these modalities in this age group is not biased by health or cultural variables. However, a higher dropout rate was associated with higher technology and more frequent assessments. This is an important observation because, while more frequent assessment may yield more stable measures, this may come at a cost of greater attrition.
We selected both cognitive and functional outcomes to capture change that would mark the transition from "no dementia" to cognitive impairment or dementia. The cognitive outcome (Delayed recall) was comparable across arms despite very different methods of administration and scoring. Unexpectedly, the functional measure scores, captured by the questionnaires, were different across groups. Although the differences were small and all measures showed no evidence of floor effect, the level of impairment in scores for both IADL and BCFSI was least in the MIP group with KIO and IVR demonstrating more impairment. Of note, this pattern was also seen in the pilot study 9 and may have been due to differences in format across the arms (paper-and-pencil for MIP vs. interactive questions by the automated examiner in KIO and IVR). These differences will be assessed further in the longitudinal phase of this zBartlett test for homogeneity of variance was significant (P < 0.001) in the 1-way ANOVA. Therefore, P values were based on Welch t tests with unequal variances and Hochberg adjusted pairwise comparisons.
ANOVA indicates analysis of variance; BCFSI, Brief Cognitive Function Self-Inventory; IADL, Instrumental Activities of Daily Living; IVR, interactive voice recognition; KIO, internet-based computer Kiosk; MIP, mail-in/phone; NS, not significant. study, along with the empirical question of differential sensitivity to worsening across arms.
The efficiency measures used in the study are a novel approach to assessing the feasibility of use of technology in clinical trials. We found longer times to study initiation (days to baseline) and greater staff time associated with the KIO. Staff expenditure was not quantified for dropouts before baseline; if these data had been available and included in the efficiency measures (ie, efficiency as a function both of time to recruit and to assess the cohort) the KIO arm would have fared even worse. Going forward staff time will continue to be required for cognitive assessment in MIP for all follow-up study visits while staff time for KIO and IVR will not be required. It is possible that this advantage of automated assessment could mitigate the start-up efficiency differences or even change the order of relative efficiency over the course of this 4-year trial, as was suggested in our HBA pilot study that included a 1-month follow-up. 2 However, this is a matter of empirical investigation for a later report.
Several of the observations made here may be very specific to this study. For example, the computerized version of our evaluation (KIO) is a self-administered procedure, quite different from tester-assisted computerized testing; the time to train and set up the procedures may not reflect the experience of in-clinic computer testing. Nevertheless, the higher dropout for those assigned to the KIO arm even before the experimental procedures were in place suggests that computer interaction may not be welcome for this age cohort. Reasons for discontinuation once the baseline procedures had begun, particularly from the KIO and IVR, often reflected challenges of technology. It may also be expected that in the future many of these technological challenges may be lessened by improvements, such as smaller footprints using tablet computers and increased familiarity with technology for future cohorts of elders. We also acknowledge that although in-home assessment may allow us to expand the range of elders who might participate in research, it may be less desirable to some who would prefer the experience of a clinic visit with face-to-face staff interaction.
In summary, this work demonstrates the feasibility of recruiting and evaluating a community cohort and of conducting the assessments at home using a range of technology. This study also quantifies novel measures of efficiency. The longitudinal aspect of the study will allow us to assess the sensitivity of HBA methods to capture the earliest transitions to cognitive impairment and dementia.
